Literature DB >> 25155554

Conditional knockouts generated by engineered CRISPR-Cas9 endonuclease reveal the roles of coronin in C. elegans neural development.

Zhongfu Shen1, Xianliang Zhang1, Yongping Chai1, Zhiwen Zhu1, Peishan Yi1, Guoxin Feng1, Wei Li2, Guangshuo Ou3.   

Abstract

Conditional gene knockout animals are valuable tools for studying the mechanisms underlying cell and developmental biology. We developed a conditional knockout strategy by spatiotemporally manipulating the expression of an RNA-guided DNA endonuclease, CRISPR-Cas9, in Caenorhabditis elegans somatic cell lineages. We showed that this somatic CRISPR-Cas9 technology provides a quick and efficient approach to generate conditional knockouts in various cell types at different developmental stages. Furthermore, we demonstrated that this method outperforms our recently developed somatic TALEN technique and enables the one-step generation of multiple conditional knockouts. By combining these techniques with live-cell imaging, we showed that an essential embryonic gene, Coronin, which is associated with human neurobehavioral dysfunction, regulates actin organization and cell morphology during C. elegans postembryonic neuroblast migration and neuritogenesis. We propose that the somatic CRISPR-Cas9 platform is uniquely suited for conditional gene editing-based biomedical research.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25155554     DOI: 10.1016/j.devcel.2014.07.017

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  70 in total

1.  The polarity protein VANG-1 antagonizes Wnt signaling by facilitating Frizzled endocytosis.

Authors:  Chun-Wei He; Chien-Po Liao; Chung-Kuan Chen; Jérôme Teulière; Chun-Hao Chen; Chun-Liang Pan
Journal:  Development       Date:  2018-12-17       Impact factor: 6.868

2.  Autism-associated missense genetic variants impact locomotion and neurodevelopment in Caenorhabditis elegans.

Authors:  Wan-Rong Wong; Katherine I Brugman; Shayda Maher; Jun Young Oh; Kevin Howe; Mihoko Kato; Paul W Sternberg
Journal:  Hum Mol Genet       Date:  2019-07-01       Impact factor: 6.150

3.  Conserved gene regulatory module specifies lateral neural borders across bilaterians.

Authors:  Yongbin Li; Di Zhao; Takeo Horie; Geng Chen; Hongcun Bao; Siyu Chen; Weihong Liu; Ryoko Horie; Tao Liang; Biyu Dong; Qianqian Feng; Qinghua Tao; Xiao Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

Review 4.  The expanding spectrum of human coronin 1A deficiency.

Authors:  Despina Moshous; Jean-Pierre de Villartay
Journal:  Curr Allergy Asthma Rep       Date:  2014-12       Impact factor: 4.806

5.  Photoactivatable CRISPR-Cas9 for optogenetic genome editing.

Authors:  Yuta Nihongaki; Fuun Kawano; Takahiro Nakajima; Moritoshi Sato
Journal:  Nat Biotechnol       Date:  2015-06-15       Impact factor: 54.908

6.  Dramatic enhancement of genome editing by CRISPR/Cas9 through improved guide RNA design.

Authors:  Behnom Farboud; Barbara J Meyer
Journal:  Genetics       Date:  2015-02-18       Impact factor: 4.562

7.  A New Tool for Inducible Gene Expression in Caenorhabditis elegans.

Authors:  Gabriela C Monsalve; Keith R Yamamoto; Jordan D Ward
Journal:  Genetics       Date:  2018-11-30       Impact factor: 4.562

8.  A toolkit for GFP-mediated tissue-specific protein degradation in C. elegans.

Authors:  Shaohe Wang; Ngang Heok Tang; Pablo Lara-Gonzalez; Zhiling Zhao; Dhanya K Cheerambathur; Bram Prevo; Andrew D Chisholm; Arshad Desai; Karen Oegema
Journal:  Development       Date:  2017-06-15       Impact factor: 6.868

9.  Targeted Mutagenesis of Duplicated Genes in Caenorhabditis elegans Using CRISPR-Cas9.

Authors:  Suhong Xu; Zhiping Wang; Kyung Won Kim; Yishi Jin; Andrew D Chisholm
Journal:  J Genet Genomics       Date:  2016-01-25       Impact factor: 4.275

Review 10.  Applications of CRISPR-Cas systems in neuroscience.

Authors:  Matthias Heidenreich; Feng Zhang
Journal:  Nat Rev Neurosci       Date:  2015-12-10       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.